A variety of cytokines produced by immune cells are uniquely characteristic of patients with IBD, including tumor necrosis factor (TNF), interleukin (IL)-6, and IL-1β, which are critical drivers of inflammatory impairment (Figure 1) [4]. The gene discussed is TNF; the disease is inflammatory bowel disease.